Uremic Pruritus
Also known as: Uremic pruritis / Uremic pruritus (disorder) / Uraemic pruritus
Drug | Drug Name | Drug Description |
---|---|---|
DB00904 | Ondansetron | A serotonin 5-HT3 receptor antagonist used to prevent nausea and vomiting in cancer chemotherapy and postoperatively. |
DB01041 | Thalidomide | A medication used to treat cancers, particularly newly diagnosed multiple myeloma, and erythema nodosum leprosum. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB17412 | Gemogenovatucel-T | 0 | Unknown Status | 1 |
DB00844 | Nalbuphine | 1 | Completed | 1 |
DB11938 | Difelikefalin | 2 | Completed | 2 |
DB13471 | Nalfurafine | 2 | Terminated | 1 |
DB01104 | Sertraline | 2 | Completed | 1 |
DB11938 | Difelikefalin | 2 / 3 | Completed | 1 |
DB00844 | Nalbuphine | 2 / 3 | Completed | 2 |
DB11938 | Difelikefalin | 3 | Completed | 5 |
DB11938 | Difelikefalin | 3 | Recruiting | 1 |
DB09278 | Activated charcoal | 4 | Completed | 1 |
DB01142 | Doxepin | 4 | Completed | 1 |
DB00950 | Fexofenadine | 4 | Unknown Status | 1 |
DB00996 | Gabapentin | 4 | Completed | 1 |
DB00230 | Pregabalin | 4 | Unknown Status | 2 |
DB01041 | Thalidomide | 4 | Not Yet Recruiting | 1 |
DB11938 | Difelikefalin | Not Available | Approved for Marketing | 1 |